» Articles » PMID: 20435026

Age and Sex Dependent Genetic Effects of Neuropeptide Y Promoter Polymorphism on Susceptibility to Ischemic Stroke in Koreans

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 2010 May 4
PMID 20435026
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In our previous study, the neuropeptide Y (NPY) C-399T promoter polymorphism (rs16147C>T) was identified as a risk factor for ischemic stroke in Koreans. In this study, we investigated whether age and sex modify the genetic effect of C-399T on susceptibility to ischemic stroke.

Methods: A total of 1,350 subjects (802 ischemic stroke patients, 548 healthy controls) were genotyped for C-399T using a primer extension method. The results were statistically analyzed for the genetic association of C-399T with ischemic stroke and clinical parameters.

Results: The TT genotype for C-399T was observed at a significantly lower frequency in stroke patients relative to control (CC+CT vs. TT, odds ratio [OR]=0.578, 95% confidence interval [95% CI]=0.360-0.927, P<0.05). This trend was also observed in female (OR=0.495, 95% CI=0.240-1.022) and older subjects (y>60, OR=0.556, 95% CI=0.304-1.018) with borderline statistical significance (P=0.0571 and P=0.0574, respectively). However, C-399T allele frequency was not different between controls and stroke patients in any groups. The C-399T polymorphism was found to be associated with body mass index and levels of some blood lipids.

Conclusions: The C-399T NPY promoter polymorphism should be considered a genetic risk factor for ischemic stroke in the older adult and female Korean populations.

Citing Articles

Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke.

Dong W, Lu Y, Long J, Peng Y, Ju Z, Xu T Eur J Neurol. 2024; 32(1):e16548.

PMID: 39575855 PMC: 11625910. DOI: 10.1111/ene.16548.


Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.

Yeo X, Cunliffe G, Ho R, Lee S, Jung S Biomedicines. 2022; 10(2).

PMID: 35203552 PMC: 8961788. DOI: 10.3390/biomedicines10020343.


Serum Neuropeptide Y: A Potential Prognostic Marker of Intracerebral Hemorrhage.

Sun W, Zhang Z, Feng X, Sui X, Miao Y Dis Markers. 2021; 2021:7957013.

PMID: 34422139 PMC: 8371617. DOI: 10.1155/2021/7957013.


The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke.

Pawluk H, Wozniak A, Grzesk G, Kolodziejska R, Kozakiewicz M, Kopkowska E Clin Interv Aging. 2020; 15:469-484.

PMID: 32273689 PMC: 7110925. DOI: 10.2147/CIA.S233909.


Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke.

Kim D, Yoo S, Chon J, Yun D, Kim H, Park H J Korean Med Sci. 2016; 31(3):430-4.

PMID: 26955245 PMC: 4779869. DOI: 10.3346/jkms.2016.31.3.430.